Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Lot 2026 appears on 8 different vendors — either a reseller relationship or a recycled COA. Compare the underlying COAs below.
Aggregated across 21 COAs for this batch
Tested by: Janoshik Analytical
| Vendor | Peptide | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| SSR | Tirzepatide | Janoshik Analytical | 99.89% | 2026-04-15 | ||
| Hkuppeptide | Retatrutide | Janoshik Analytical | 99.82% | 2026-04-14 | ||
| Hkuppeptide |
| Janoshik Analytical |
| 99.81% |
| 2026-04-14 |
| Vicopeptide | GHK-Cu | Janoshik Analytical | 99.44% | 2026-04-14 |
| Taishijie | Tirzepatide | Janoshik Analytical | 99.81% | 2026-04-14 |
| Peptiatlas | Tirzepatide | Janoshik Analytical | 99.81% | 2026-04-14 |
| Taishijie | Retatrutide | Janoshik Analytical | 99.82% | 2026-04-14 |
| Peptiatlas | GHK-Cu | Janoshik Analytical | 99.44% | 2026-04-14 |
| Vicopeptide | Tirzepatide | Janoshik Analytical | 99.81% | 2026-04-14 |
| Zjpeptix | Tirzepatide | Janoshik Analytical | 99.81% | 2026-04-14 |
| Peptiatlas | Retatrutide | Janoshik Analytical | 99.82% | 2026-04-14 |
| Hkuppeptide | GHK-Cu | Janoshik Analytical | 99.44% | 2026-04-14 |
| Taikangbio | GHK-Cu | Janoshik Analytical | 99.44% | 2026-04-14 |
| Taishijie | GHK-Cu | Janoshik Analytical | 99.44% | 2026-04-14 |
| Taikangbio | Retatrutide | Janoshik Analytical | 99.82% | 2026-04-14 |
| Taikangbio | Tirzepatide | Janoshik Analytical | 99.81% | 2026-04-14 |
| Zjpeptix | GHK-Cu | Janoshik Analytical | 99.44% | 2026-04-14 |
| Zjpeptix | Retatrutide | Janoshik Analytical | 99.82% | 2026-04-14 |
| Vicopeptide | Retatrutide | Janoshik Analytical | 99.82% | 2026-04-14 |
| Mandy | Retatrutide | Janoshik Analytical | 99.90% | 2026-01-23 |
| Mandy | rHGH | Janoshik Analytical | 97.31% | 2025-12-30 |